APO Research

APO RESEARCH · REPORT

Immune System Allergy Treatment

Selected research

Market Structure

Global Immune System Allergy Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Immune System Allergy Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Immune System Allergy Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Immune System Allergy Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immune System Allergy Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Immune System Allergy Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Immune System Allergy Treatment include Sanofi, Johnson and Johnson Services, Inc., Pfizer Inc., GlaxoSmithKline plc, Stallergenes Greer, LETIPharma, Dermapharm Holding, Allergy Therapeutics and Allergan plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Immune System Allergy Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Immune System Allergy Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immune System Allergy Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Immune System Allergy Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Immune System Allergy Treatment Segment by Company

Sanofi

Johnson and Johnson Services, Inc.

Pfizer Inc.

GlaxoSmithKline plc

Stallergenes Greer

LETIPharma

Dermapharm Holding

Allergy Therapeutics

Allergan plc

ALK-Abelló A/S

Immune System Allergy Treatment Segment by Type

Allergy Injection

Sublingual Immunotherapy

Immune System Allergy Treatment Segment by Application

Hospital

Clinic

Others

Immune System Allergy Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune System Allergy Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immune System Allergy Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune System Allergy Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Immune System Allergy Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Immune System Allergy Treatment industry.

Chapter 3: Detailed analysis of Immune System Allergy Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immune System Allergy Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Immune System Allergy Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Allergy Injection Table 3. Key Players of Sublingual Immunotherapy Table 4. Global Immune System Allergy Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Others Table 8. Global Immune System Allergy Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Immune System Allergy Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Immune System Allergy Treatment Market Share by Region (2021-2026) Table 11. Global Immune System Allergy Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Immune System Allergy Treatment Market Share by Region (2027-2032) Table 13. Immune System Allergy Treatment Industry Trends Table 14. Immune System Allergy Treatment Industry Drivers Table 15. Immune System Allergy Treatment Industry Opportunities and Challenges Table 16. Immune System Allergy Treatment Industry Restraints Table 17. Global Immune System Allergy Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Immune System Allergy Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Immune System Allergy Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Immune System Allergy Treatment Key Company Head Office and Area Served Table 21. Global Immune System Allergy Treatment Company, Product Type & Application Table 22. Global Immune System Allergy Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Immune System Allergy Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Immune System Allergy Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Immune System Allergy Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Immune System Allergy Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Immune System Allergy Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Immune System Allergy Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Immune System Allergy Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Immune System Allergy Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Immune System Allergy Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Immune System Allergy Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Immune System Allergy Treatment Revenue Market Share by Application (2027-2032) Table 35. Sanofi Company Information Table 36. Sanofi Business Overview Table 37. Sanofi Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Sanofi Immune System Allergy Treatment Product Portfolio Table 39. Sanofi Recent Development Table 40. Johnson and Johnson Services, Inc. Company Information Table 41. Johnson and Johnson Services, Inc. Business Overview Table 42. Johnson and Johnson Services, Inc. Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Johnson and Johnson Services, Inc. Immune System Allergy Treatment Product Portfolio Table 44. Johnson and Johnson Services, Inc. Recent Development Table 45. Pfizer Inc. Company Information Table 46. Pfizer Inc. Business Overview Table 47. Pfizer Inc. Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Pfizer Inc. Immune System Allergy Treatment Product Portfolio Table 49. Pfizer Inc. Recent Development Table 50. GlaxoSmithKline plc Company Information Table 51. GlaxoSmithKline plc Business Overview Table 52. GlaxoSmithKline plc Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. GlaxoSmithKline plc Immune System Allergy Treatment Product Portfolio Table 54. GlaxoSmithKline plc Recent Development Table 55. Stallergenes Greer Company Information Table 56. Stallergenes Greer Business Overview Table 57. Stallergenes Greer Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Stallergenes Greer Immune System Allergy Treatment Product Portfolio Table 59. Stallergenes Greer Recent Development Table 60. LETIPharma Company Information Table 61. LETIPharma Business Overview Table 62. LETIPharma Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. LETIPharma Immune System Allergy Treatment Product Portfolio Table 64. LETIPharma Recent Development Table 65. Dermapharm Holding Company Information Table 66. Dermapharm Holding Business Overview Table 67. Dermapharm Holding Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Dermapharm Holding Immune System Allergy Treatment Product Portfolio Table 69. Dermapharm Holding Recent Development Table 70. Allergy Therapeutics Company Information Table 71. Allergy Therapeutics Business Overview Table 72. Allergy Therapeutics Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Allergy Therapeutics Immune System Allergy Treatment Product Portfolio Table 74. Allergy Therapeutics Recent Development Table 75. Allergan plc Company Information Table 76. Allergan plc Business Overview Table 77. Allergan plc Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Allergan plc Immune System Allergy Treatment Product Portfolio Table 79. Allergan plc Recent Development Table 80. ALK-Abelló A/S Company Information Table 81. ALK-Abelló A/S Business Overview Table 82. ALK-Abelló A/S Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. ALK-Abelló A/S Immune System Allergy Treatment Product Portfolio Table 84. ALK-Abelló A/S Recent Development Table 85. North America Immune System Allergy Treatment Market Size by Type (2021-2026) & (US$ Million) Table 86. North America Immune System Allergy Treatment Market Size by Type (2027-2032) & (US$ Million) Table 87. North America Immune System Allergy Treatment Market Size by Application (2021-2026) & (US$ Million) Table 88. North America Immune System Allergy Treatment Market Size by Application (2027-2032) & (US$ Million) Table 89. North America Immune System Allergy Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Immune System Allergy Treatment Market Size by Country (2021-2026) Table 91. North America Immune System Allergy Treatment Market Size by Country (2027-2032) Table 92. Europe Immune System Allergy Treatment Market Size by Type (2021-2026) & (US$ Million) Table 93. Europe Immune System Allergy Treatment Market Size by Type (2027-2032) & (US$ Million) Table 94. Europe Immune System Allergy Treatment Market Size by Application (2021-2026) & (US$ Million) Table 95. Europe Immune System Allergy Treatment Market Size by Application (2027-2032) & (US$ Million) Table 96. Europe Immune System Allergy Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Immune System Allergy Treatment Market Size by Country (2021-2026) Table 98. Europe Immune System Allergy Treatment Market Size by Country (2027-2032) Table 99. China Immune System Allergy Treatment Market Size by Type (2021-2026) & (US$ Million) Table 100. China Immune System Allergy Treatment Market Size by Type (2027-2032) & (US$ Million) Table 101. China Immune System Allergy Treatment Market Size by Application (2021-2026) & (US$ Million) Table 102. China Immune System Allergy Treatment Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia Immune System Allergy Treatment Market Size by Type (2021-2026) & (US$ Million) Table 104. Asia Immune System Allergy Treatment Market Size by Type (2027-2032) & (US$ Million) Table 105. Asia Immune System Allergy Treatment Market Size by Application (2021-2026) & (US$ Million) Table 106. Asia Immune System Allergy Treatment Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia Immune System Allergy Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Immune System Allergy Treatment Market Size by Country (2021-2026) Table 109. Asia Immune System Allergy Treatment Market Size by Country (2027-2032) Table 110. South America, Middle East & Africa Immune System Allergy Treatment Market Size by Type (2021-2026) & (US$ Million) Table 111. South America, Middle East & Africa Immune System Allergy Treatment Market Size by Type (2027-2032) & (US$ Million) Table 112. South America, Middle East & Africa Immune System Allergy Treatment Market Size by Application (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa Immune System Allergy Treatment Market Size by Application (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa Immune System Allergy Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. South America, Middle East & Africa Immune System Allergy Treatment Market Size by Country (2021-2026) Table 116. South America, Middle East & Africa Immune System Allergy Treatment Market Size by Country (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Immune System Allergy Treatment Product Image Figure 2. Global Immune System Allergy Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Immune System Allergy Treatment Market Share by Type: 2025 VS 2032 Figure 4. Allergy Injection Image Figure 5. Sublingual Immunotherapy Image Figure 6. Global Immune System Allergy Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Immune System Allergy Treatment Market Share by Application: 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Immune System Allergy Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 13. Global Immune System Allergy Treatment Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Immune System Allergy Treatment Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Immune System Allergy Treatment Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Immune System Allergy Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Immune System Allergy Treatment Revenue Market Share by Type (2021-2032) Figure 20. Global Immune System Allergy Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Immune System Allergy Treatment Revenue Market Share by Application (2021-2032) Figure 22. North America Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 23. North America Immune System Allergy Treatment Market Share by Type (2021-2032) Figure 24. North America Immune System Allergy Treatment Market Share by Application (2021-2032) Figure 25. North America Immune System Allergy Treatment Market Share by Country (2021-2032) Figure 26. United States Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 27. Canada Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Europe Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Europe Immune System Allergy Treatment Market Share by Type (2021-2032) Figure 31. Europe Immune System Allergy Treatment Market Share by Application (2021-2032) Figure 32. Europe Immune System Allergy Treatment Market Share by Country (2021-2032) Figure 33. Germany Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 34. France Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 36. Italy Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 37. Russia Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 39. China Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 40. China Immune System Allergy Treatment Market Share by Type (2021-2032) Figure 41. China Immune System Allergy Treatment Market Share by Application (2021-2032) Figure 42. Asia Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 43. Asia Immune System Allergy Treatment Market Share by Type (2021-2032) Figure 44. Asia Immune System Allergy Treatment Market Share by Application (2021-2032) Figure 45. Asia Immune System Allergy Treatment Market Share by Country (2021-2032) Figure 46. Japan Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 50. India Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Australia Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Immune System Allergy Treatment Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Immune System Allergy Treatment Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Immune System Allergy Treatment Market Share by Country (2021-2032) Figure 56. Brazil Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 61. UAE Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Chile Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Allergy Injection
  • Sublingual Immunotherapy
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Sanofi
  • Johnson and Johnson Services, Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Stallergenes Greer
  • LETIPharma
  • Dermapharm Holding
  • Allergy Therapeutics
  • Allergan plc
  • ALK-Abelló A/S

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Immune System Allergy Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Allergy Injection
  5. 1.2.3 Sublingual Immunotherapy
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Immune System Allergy Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Immune System Allergy Treatment Growth Trends by Region
  13. 1.5.1 Global Immune System Allergy Treatment Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Immune System Allergy Treatment Market Size by Region (2021-2026)
  15. 1.5.3 Immune System Allergy Treatment Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Immune System Allergy Treatment Market Dynamics
  1. 2.1 Immune System Allergy Treatment Industry Trends
  2. 2.2 Immune System Allergy Treatment Industry Drivers
  3. 2.3 Immune System Allergy Treatment Industry Opportunities and Challenges
  4. 2.4 Immune System Allergy Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Immune System Allergy Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Immune System Allergy Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Immune System Allergy Treatment Key Company Head office and Area Served
  4. 3.4 Global Immune System Allergy Treatment Company, Product Type & Application
  5. 3.5 Global Immune System Allergy Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Immune System Allergy Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Immune System Allergy Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Immune System Allergy Treatment Tier 1, Tier 2, and Tier 3
4 Immune System Allergy Treatment Market by Type
  1. 4.1 Global Immune System Allergy Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Immune System Allergy Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Immune System Allergy Treatment Market Size Share by Type (2021-2032)
5 Immune System Allergy Treatment Market by Application
  1. 5.1 Global Immune System Allergy Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Immune System Allergy Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Immune System Allergy Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Sanofi Immune System Allergy Treatment Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Johnson and Johnson Services, Inc.
  8. 6.2.1 Johnson and Johnson Services, Inc. Company Information
  9. 6.2.2 Johnson and Johnson Services, Inc. Business Overview
  10. 6.2.3 Johnson and Johnson Services, Inc. Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Johnson and Johnson Services, Inc. Immune System Allergy Treatment Product Portfolio
  12. 6.2.5 Johnson and Johnson Services, Inc. Recent Developments
  13. 6.3 Pfizer Inc.
  14. 6.3.1 Pfizer Inc. Company Information
  15. 6.3.2 Pfizer Inc. Business Overview
  16. 6.3.3 Pfizer Inc. Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Pfizer Inc. Immune System Allergy Treatment Product Portfolio
  18. 6.3.5 Pfizer Inc. Recent Developments
  19. 6.4 GlaxoSmithKline plc
  20. 6.4.1 GlaxoSmithKline plc Company Information
  21. 6.4.2 GlaxoSmithKline plc Business Overview
  22. 6.4.3 GlaxoSmithKline plc Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 GlaxoSmithKline plc Immune System Allergy Treatment Product Portfolio
  24. 6.4.5 GlaxoSmithKline plc Recent Developments
  25. 6.5 Stallergenes Greer
  26. 6.5.1 Stallergenes Greer Company Information
  27. 6.5.2 Stallergenes Greer Business Overview
  28. 6.5.3 Stallergenes Greer Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Stallergenes Greer Immune System Allergy Treatment Product Portfolio
  30. 6.5.5 Stallergenes Greer Recent Developments
  31. 6.6 LETIPharma
  32. 6.6.1 LETIPharma Company Information
  33. 6.6.2 LETIPharma Business Overview
  34. 6.6.3 LETIPharma Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 LETIPharma Immune System Allergy Treatment Product Portfolio
  36. 6.6.5 LETIPharma Recent Developments
  37. 6.7 Dermapharm Holding
  38. 6.7.1 Dermapharm Holding Company Information
  39. 6.7.2 Dermapharm Holding Business Overview
  40. 6.7.3 Dermapharm Holding Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Dermapharm Holding Immune System Allergy Treatment Product Portfolio
  42. 6.7.5 Dermapharm Holding Recent Developments
  43. 6.8 Allergy Therapeutics
  44. 6.8.1 Allergy Therapeutics Company Information
  45. 6.8.2 Allergy Therapeutics Business Overview
  46. 6.8.3 Allergy Therapeutics Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Allergy Therapeutics Immune System Allergy Treatment Product Portfolio
  48. 6.8.5 Allergy Therapeutics Recent Developments
  49. 6.9 Allergan plc
  50. 6.9.1 Allergan plc Company Information
  51. 6.9.2 Allergan plc Business Overview
  52. 6.9.3 Allergan plc Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Allergan plc Immune System Allergy Treatment Product Portfolio
  54. 6.9.5 Allergan plc Recent Developments
  55. 6.10 ALK-Abelló A/S
  56. 6.10.1 ALK-Abelló A/S Company Information
  57. 6.10.2 ALK-Abelló A/S Business Overview
  58. 6.10.3 ALK-Abelló A/S Immune System Allergy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 ALK-Abelló A/S Immune System Allergy Treatment Product Portfolio
  60. 6.10.5 ALK-Abelló A/S Recent Developments
7 North America
  1. 7.1 North America Immune System Allergy Treatment Market Size (2021-2032)
  2. 7.2 North America Immune System Allergy Treatment Market Size by Type
  3. 7.2.1 North America Immune System Allergy Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Immune System Allergy Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Immune System Allergy Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Immune System Allergy Treatment Market Size by Application
  7. 7.3.1 North America Immune System Allergy Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Immune System Allergy Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Immune System Allergy Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Immune System Allergy Treatment Market Size by Country
  11. 7.4.1 North America Immune System Allergy Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Immune System Allergy Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Immune System Allergy Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Immune System Allergy Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Immune System Allergy Treatment Market Size (2021-2032)
  2. 8.2 Europe Immune System Allergy Treatment Market Size by Type
  3. 8.2.1 Europe Immune System Allergy Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Immune System Allergy Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Immune System Allergy Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Immune System Allergy Treatment Market Size by Application
  7. 8.3.1 Europe Immune System Allergy Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Immune System Allergy Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Immune System Allergy Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Immune System Allergy Treatment Market Size by Country
  11. 8.4.1 Europe Immune System Allergy Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Immune System Allergy Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Immune System Allergy Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Immune System Allergy Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Immune System Allergy Treatment Market Size (2021-2032)
  2. 9.2 China Immune System Allergy Treatment Market Size by Type
  3. 9.2.1 China Immune System Allergy Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Immune System Allergy Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Immune System Allergy Treatment Market Share by Type (2021-2032)
  6. 9.3 China Immune System Allergy Treatment Market Size by Application
  7. 9.3.1 China Immune System Allergy Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Immune System Allergy Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Immune System Allergy Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Immune System Allergy Treatment Market Size (2021-2032)
  2. 10.2 Asia Immune System Allergy Treatment Market Size by Type
  3. 10.2.1 Asia Immune System Allergy Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Immune System Allergy Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Immune System Allergy Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Immune System Allergy Treatment Market Size by Application
  7. 10.3.1 Asia Immune System Allergy Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Immune System Allergy Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Immune System Allergy Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Immune System Allergy Treatment Market Size by Country
  11. 10.4.1 Asia Immune System Allergy Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Immune System Allergy Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Immune System Allergy Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Immune System Allergy Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Immune System Allergy Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Immune System Allergy Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Immune System Allergy Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Immune System Allergy Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Immune System Allergy Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Immune System Allergy Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Immune System Allergy Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Immune System Allergy Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Immune System Allergy Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Immune System Allergy Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Immune System Allergy Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Immune System Allergy Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Immune System Allergy Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Immune System Allergy Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research